MLL
Magazine

As a highly innovative company, we are well aware of the responsibility we bear for creating the world of tomorrow. With this in mind, we have successfully established an ISO 14001 based professional environmental management system in all of our sections and processes. In one assessment, our efforts were verified by the neutral and accredited certification body DEKRA (see ISO 14001 certificate).

In December 2020, the 62nd Annual Meeting & Exposition of the American Society of Hematology (ASH) took place, for the first time in virtual format. At the world's largest hematology congress, international experts gathered for five days to exchange the latest hematology findings and learn about the current state of research. This time, too, the MLL Munich Leukemia Laboratory was there. A total of 12 scientists presented their current research projects. You can find out which ones in this article.

The MLL Munich Leukemia Laboratory is generally associated with specialist hematological diagnostics and innovation. The MHP Munich Hematology Practice is another organ which is involved in insurance-funded and private medical care of patients in the Munich metropolitan area. In this article we would like to introduce you to MHP.

The consortium of GenoMed4All - Genomics and Personalised Medicine for all through Artificial Intelligence in Haematological Diseases is pleased to announce the launch of an ambitious joint initiative selected and granted by the European Commission under the Horizon 2020 Research & Innovation programme. The MLL Munich Leukemia Laboratory is also part of this initiative.